These remarkable results revealed that the KXRG capsules prevented and treated NAFLD fibrosis in rats, possibly via the regulation of the TGF-β and TLR4 signaling pathways. Here, TGFB1 is linked to metabolic dysfunction-associated steatotic liver disease.